BCRX 241220 1.00C (BCRX241220C1000) Stock Options, News & Quotes

6.50
+1.40+27.45%

15min DelayClose Dec 20 16:00 ET

6.50High6.50Low

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Jaguar8

Dec 18 19:33

🟢 Watchlist THURSDAY December 19,2024. NFA!

NOTE!
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Check current shorts availability on FINTEL.io
4. Scale out and secure profits
5. Always remember shorts include dark pools.
6. Most importantly, don’t blame for your losses. I already give watchlist and stock education. The ball is on you.
7. I DO NOT give buy or sell advice
8. COH (cash on hand); AH (after hours): RTH (regular trading hours)
$Currenc Group (CURR.US)$ Despac Sk...

Jaguar8

Dec 18 16:37

Bird Flu stocks on watch this week. Make an entire watchlist specifically for bird flu, AI, Quantum, Drone, War, China stocks. Just a helpful tip.

$China SXT Pharmaceuticals (SXTC.US)$ $TOMI Environmental Solutions (TOMZ.US)$ $Aethlon Medical (AEMD.US)$ $GeoVax Labs (GOVX.US)$ $Nanoviricides (NNVC.US)$ $CureVac (CVAC.US)$ $BioCryst Pharmaceuticals (BCRX.US)$ $Inovio Pharmaceuticals (INO.US)$ $Tonix Pharmaceuticals (TNXP.US)$ $Virax Biolabs (VRAX.US)$
California Gov. Gavin Newsom declares state of emergency over bird flu, calling it a "proactive action" - CBS Sacramento

Jaguar8

Nov 7 09:30

13G

$BioCryst Pharmaceuticals (BCRX.US)$
BioCryst Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(9.81%)

frogoracletrading

Nov 4 06:06

$BCRX Support / Resistance Levels

Here are the levels to watch this week.
Larger Image: tradingview.com...
$BioCryst Pharmaceuticals (BCRX.US)$

Trytosaveabit

Oct 14 06:13

Update

$BioCryst Pharmaceuticals (BCRX.US)$ BioCryst's ORLADEYO Reduces Hospital Visits and Emergency Care for Hereditary Angioedema Patients, Study Shows
Benzinga· 3 mins ago
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new real-world evidence on the use of oral, once-daily ORLADEYO (berotralstat) demonstrating that patients with hereditary angioedema (HAE) in the United States experience significant reductions in healthcare resource utilization (HRU), including significant reduc...